Gaia Skibinski
Gaia Skibinski
Verified email at
Cited by
Cited by
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
G Skibinski, NJ Parkinson, JM Brown, L Chakrabarti, SL Lloyd, ...
Nature genetics 37 (8), 806-808, 2005
Direct membrane association drives mitochondrial fission by the parkinson disease-associated protein α-Synuclein*♦
K Nakamura, VM Nemani, F Azarbal, G Skibinski, JM Levy, K Egami, ...
Journal of Biological Chemistry 286 (23), 20710-20726, 2011
Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis
SJ Barmada, G Skibinski, E Korb, EJ Rao, JY Wu, S Finkbeiner
Journal of Neuroscience 30 (2), 639-649, 2010
In silico labeling: predicting fluorescent labels in unlabeled images
EM Christiansen, SJ Yang, DM Ando, A Javaherian, G Skibinski, S Lipnick, ...
Cell 173 (3), 792-803. e19, 2018
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
N Parkinson, PG Ince, MO Smith, R Highley, G Skibinski, PM Andersen, ...
Neurology 67 (6), 1074-1077, 2006
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies
G Skibinski, K Nakamura, MR Cookson, S Finkbeiner
Journal of Neuroscience 34 (2), 418-433, 2014
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson’s disease
G Toth, SJ Gardai, W Zago, CW Bertoncini, N Cremades, SL Roy, ...
PloS one 9 (2), e87133, 2014
Nrf2 mitigates LRRK2-and α-synuclein–induced neurodegeneration by modulating proteostasis
G Skibinski, V Hwang, DM Ando, A Daub, AK Lee, A Ravisankar, ...
Proceedings of the National Academy of Sciences 114 (5), 1165-1170, 2017
iPS cells in the study of PD molecular pathogenesis
MM Cobb, A Ravisankar, G Skibinski, S Finkbeiner
Cell and tissue research 373, 61-77, 2018
Drug discovery in Parkinson's disease: update and developments in the use of cellular models
G Skibinski, S Finkbeiner
International journal of high throughput screening, 15-25, 2011
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity
AED Stormo, F Shavarebi, M FitzGibbon, EM Earley, H Ahrendt, LS Lum, ...
Journal of Cell Biology 221 (4), e202010065, 2022
MRC Proteomics in ALS Study
N Parkinson, PG Ince, MO Smith, R Highley, G Skibinski, PM Andersen, ...
FReJA Consortium ALS phenotypes with mutations in CHMP2B (charged …, 2006
Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease
G Skibinski, S Finkbeiner
FEBS letters 587 (8), 1139-1146, 2013
Frontotemporal dementia linked to chromosome 3
J Brown, S Gydesen, P Johannsen, A Gade, G Skibinski, L Chakrabarti, ...
Dementia and geriatric cognitive disorders 17 (4), 274-276, 2004
Optimization and scaling of patient-derived brain organoids uncovers deep phenotypes of disease
K Shah, R Bedi, A Rogozhnikov, P Ramkumar, Z Tong, B Rash, M Stanton, ...
bioRxiv, 2020.08. 26.251611, 2020
A three-groups model for high-throughput survival screens
BA Shaby, G Skibinski, M Ando, ES LaDow, S Finkbeiner
Biometrics 72 (3), 936-944, 2016
Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W …
G Novak, S Finkbeiner, G Skibinski, M Bernini, C Donato, A Skupin
Stem Cell Research 61, 102765, 2022
Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)
G Novak, S Finkbeiner, G Skibinski, A Skupin
Stem Cell Research 57, 102569, 2021
Preclinical signs of impairment in persons at high risk of frontotemporal dementia related to chromosome 3 (FTD3): preliminary findings in neuropsychological tests
A Gade, G Skibinski, S Gydesen
Neurobiol Aging 25 (suppl 2), S453, 2004
Neuroimmune cortical organoids overexpressing C4A exhibit multiple schizophrenia endophenotypes
MM Stanton, S Modan, PM Taylor, HN Hariani, J Sorokin, BG Rash, ...
bioRxiv, 2023.01. 20.524955, 2023
The system can't perform the operation now. Try again later.
Articles 1–20